CORONARY SINUS LEVEL OF GALECTIN-3 IS A BETTER PREDICTOR THAN PERIPHERAL VENOUS LEVEL OF MAJOR ADVERSE CARDIAC EVENTS IN PATIENTS WITH CARDIAC RESYNCHRONIZATION THERAPY

Galectin-3 (Gal-3) is an emerging marker of cardiac fibrosis and associated with heart failure (HF) outcomes. Coronary sinus (CS) blood can be sampled readily in patients undergoing cardiac resynchronization therapy (CRT) and circulating biomarker levels may differ between vascular beds. Thus, we